0001127602-19-026232.txt : 20190807 0001127602-19-026232.hdr.sgml : 20190807 20190807165327 ACCESSION NUMBER: 0001127602-19-026232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190805 FILED AS OF DATE: 20190807 DATE AS OF CHANGE: 20190807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACMILLAN STEPHEN P CENTRAL INDEX KEY: 0001239351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36214 FILM NUMBER: 191006209 MAIL ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOLOGIC INC CENTRAL INDEX KEY: 0000859737 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 042902449 STATE OF INCORPORATION: DE FISCAL YEAR END: 0928 BUSINESS ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: 5082632900 MAIL ADDRESS: STREET 1: 250 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-08-05 0000859737 HOLOGIC INC HOLX 0001239351 MACMILLAN STEPHEN P 250 CAMPUS DRIVE MARLBOROUGH MA 01752 1 1 Chairman, President and CEO Common Stock 2019-08-05 4 M 0 215996 22.29 A 1781811 D Common Stock 2019-08-05 4 S 0 112451 48.413 D 1669360 D Common Stock 2019-08-05 4 S 0 81945 49.264 D 1587415 D Non-qualified Stock Option (Right to Buy) 22.29 2019-08-05 4 M 0 215996 0 D 2014-12-06 2020-12-06 Common Stock 215996 647988 D Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. Includes 1,045,901 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $47.985 to $48.97 per share. The Reporting Person will provide, upon request from Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (4) to this Form 4. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $48.99 to $49.76 per share. The Reporting Person will provide, upon request by Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (4) to this Form 4. /s/ Patricia K. Dolan, attorney-in-fact for Mr. MacMillan 2019-08-07